Tonix anticipates filing the IND application in the fourth quarter of 2025
Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder
Seeking Alpha / 2 hours from now 2 Views
Seeking Alpha / 2 hours from now 2 Views
Tonix anticipates filing the IND application in the fourth quarter of 2025
Comments